GOSS Relative Valuation
GOSS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, GOSS is overvalued; if below, it's undervalued.
Historical Valuation
Gossamer Bio Inc (GOSS) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -2.51. The fair price of Gossamer Bio Inc (GOSS) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price：3.42
Fair
-4.55
PE
1Y
3Y
5Y
Trailing
Forward
-7.16
EV/EBITDA
Gossamer Bio Inc. (GOSS) has a current EV/EBITDA of -7.16. The 5-year average EV/EBITDA is -2.17. The thresholds are as follows: Strongly Undervalued below -5.61, Undervalued between -5.61 and -3.89, Fairly Valued between -0.45 and -3.89, Overvalued between -0.45 and 1.27, and Strongly Overvalued above 1.27. The current Forward EV/EBITDA of -7.16 falls within the Strongly Undervalued range.
-4.35
EV/EBIT
Gossamer Bio Inc. (GOSS) has a current EV/EBIT of -4.35. The 5-year average EV/EBIT is -1.83. The thresholds are as follows: Strongly Undervalued below -4.48, Undervalued between -4.48 and -3.15, Fairly Valued between -0.50 and -3.15, Overvalued between -0.50 and 0.82, and Strongly Overvalued above 0.82. The current Forward EV/EBIT of -4.35 falls within the Undervalued range.
33.44
PS
Gossamer Bio Inc. (GOSS) has a current PS of 33.44. The 5-year average PS is 23.86. The thresholds are as follows: Strongly Undervalued below -144.47, Undervalued between -144.47 and -60.30, Fairly Valued between 108.03 and -60.30, Overvalued between 108.03 and 192.20, and Strongly Overvalued above 192.20. The current Forward PS of 33.44 falls within the Historic Trend Line -Fairly Valued range.
-6.21
P/OCF
Gossamer Bio Inc. (GOSS) has a current P/OCF of -6.21. The 5-year average P/OCF is 57.34. The thresholds are as follows: Strongly Undervalued below -491.80, Undervalued between -491.80 and -217.23, Fairly Valued between 331.91 and -217.23, Overvalued between 331.91 and 606.48, and Strongly Overvalued above 606.48. The current Forward P/OCF of -6.21 falls within the Historic Trend Line -Fairly Valued range.
-6.13
P/FCF
Gossamer Bio Inc. (GOSS) has a current P/FCF of -6.13. The 5-year average P/FCF is -43.90. The thresholds are as follows: Strongly Undervalued below -407.50, Undervalued between -407.50 and -225.70, Fairly Valued between 137.90 and -225.70, Overvalued between 137.90 and 319.70, and Strongly Overvalued above 319.70. The current Forward P/FCF of -6.13 falls within the Historic Trend Line -Fairly Valued range.
Gossamer Bio Inc (GOSS) has a current Price-to-Book (P/B) ratio of -9.61. Compared to its 3-year average P/B ratio of -1.01 , the current P/B ratio is approximately 847.87% higher. Relative to its 5-year average P/B ratio of -0.93, the current P/B ratio is about 929.21% higher. Gossamer Bio Inc (GOSS) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -59.92%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -45.78% , the current FCF yield is about -100.00% lower.
-9.33
P/B
Median3y
-1.01
Median5y
-0.93
-20.02
FCF Yield
Median3y
-59.92
Median5y
-45.78
Competitors Valuation Multiple
The average P/S ratio for GOSS's competitors is , providing a benchmark for relative valuation. Gossamer Bio Inc Corp (GOSS) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 40.23%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of GOSS increased by 267.01% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -1.53 to -4.83.
The secondary factor is the Revenue Growth, contributed 40.23%to the performance.
Overall, the performance of GOSS in the past 1 year is driven by P/E Change. Which is more unsustainable.
People Also Watch
FAQ
Is Gossamer Bio Inc (GOSS) currently overvalued or undervalued?
What is Gossamer Bio Inc (GOSS) fair value?
How does GOSS's valuation metrics compare to the industry average?
What is the current P/B ratio for Gossamer Bio Inc (GOSS) as of Dec 05 2025?
What is the current FCF Yield for Gossamer Bio Inc (GOSS) as of Dec 05 2025?
What is the current Forward P/E ratio for Gossamer Bio Inc (GOSS) as of Dec 05 2025?